-
ML216 BLM Helicase Inhibitor: Lab Workflows
2026-09-01
ML216 supports mechanism-focused studies of BLM-dependent DNA repair, from helicase unwinding assays and sister chromatid exchange measurements to cell proliferation and chemotherapy-sensitization experiments. This guide pairs practical formulation and dosing strategies with controls that help distinguish on-target BLM helicase inhibition from nonspecific cytotoxicity.
-
QNZ (EVP4593): From NF-κB Biology to Translation
2026-08-31
A translational framework for using QNZ (EVP4593) to connect NF-κB reporter activity, TNF-α biology, inflammation models, and Huntington’s disease research while maintaining evidence boundaries.
-
Cefodizime: From PBP Biology to Resistance Strategy
2026-08-31
Cefodizime is more than a broad-spectrum antibacterial agent: it is a useful translational probe for connecting penicillin-binding protein biology, susceptibility testing, immune-response assays, pharmacokinetic context, and antimicrobial stewardship. This article outlines how researchers can use Cefodizime to design more informative infection models while interpreting resistance surveillance with appropriate caution.
-
Z-VDVAD-FMK for Apoptosis Assays
2026-08-30
Z-VDVAD-FMK provides a cell-permeable, irreversible way to interrogate caspase-2-centered apoptosis alongside mitochondrial signaling and downstream caspase activity. This guide turns that mechanism into a practical workflow for cancer research while showing how to avoid confusing apoptotic rescue with caspase-1-driven pyroptosis.
-
BIBR 1532 for Reliable Telomerase Assays
2026-08-29
This scenario-driven guide explains how BIBR 1532 (SKU A1945) can improve the interpretation and reproducibility of telomerase, proliferation, viability, and apoptosis workflows. It covers solvent handling, concentration design, orthogonal readouts, leukemia-model interpretation, and practical supplier evaluation.
-
Brefeldin A: From Trafficking Block to ER Stress
2026-08-28
Brefeldin A is more than a vesicle transport inhibitor: it is a practical probe for connecting ER–Golgi trafficking failure with protein quality control and cell fate. This guide translates its mechanism, ER stress biology, and cancer-model evidence into better assay design.
-
GCRV Entry via Clathrin-Mediated Endocytosis
2026-08-28
Wang et al. used pharmacological inhibitors, transmission electron microscopy, and real-time quantitative PCR to show that genotype III grass carp reovirus GCRV104 enters CIK cells through a clathrin-mediated, dynamin-dependent, acidification-sensitive pathway. The study also demonstrates that Latrunculin B did not significantly inhibit infection under the tested conditions, an important negative result for interpreting actin-directed perturbations in viral entry research.
-
MLN4924 HCl Salt: A Mechanistic Assay Guide
2026-08-27
MLN4924 HCl salt is a selective NEDD8-activating enzyme inhibitor for dissecting cullin-RING ligase activity, proteostasis, and cell fate. This guide translates viral RIPK3-degradation research into a rigorous assay strategy that separates pathway engagement from downstream biological interpretation.
-
HotStart qPCR Master Mix for CRC Pathway Validation
2026-08-27
Discover how HotStart Universal 2X FAST Green qPCR Master Mix can support mechanism-aware gene expression analysis of the H3K18 lactylation–METTL5–CCT2 axis in colorectal cancer. This guide connects dye-based qPCR design with orthogonal validation of pyroptosis, RNA stability, and metabolic signaling.
-
TCAIM Control of OGDH: Mitochondrial Proteostasis
2026-08-26
The 2025 Molecular Cell study identifies TCAIM as a mitochondrial DNAJC co-chaperone that specifically binds native OGDH and promotes its reduction through HSPA9 and LONP1. This noncanonical proteostasis mechanism suppresses OGDH complex activity and changes carbohydrate catabolism in cultured cells and murine models, linking mitochondrial protein quality control directly to metabolic regulation.
-
Dissolving Microneedles for Risedronate Delivery
2026-08-26
The reference study developed a dissolving microneedle patch containing nanotransfersomes loaded with Risedronate Sodium and ursolic acid for transdermal osteoporosis research. Its optimized formulation combined high drug entrapment, sustained release, uniform patch loading, and substantial ex vivo skin permeation, while remaining an early-stage delivery study rather than evidence of clinical efficacy.
-
NS1–DNMT1 Control of HBoV1 Replication
2026-08-25
A 2024 PLOS Pathogens study shows that DNMT1-dependent methylation supports human bocavirus 1 DNA replication while restraining viral RNA processing. It further identifies NS1-mediated DNMT1 degradation through the ubiquitin–proteasome pathway as a mechanism that shifts the infection program toward RNA maturation and viral protein expression.
-
Aclacinomycin A: From DNA Damage to rDNA Stress
2026-08-25
Aclacinomycin A, also known as Aclarubicin, is a versatile DNA damage inducer and apoptosis model compound. This article explains how to use its topological-stress biology to distinguish persistent ribosomal DNA lesions from generalized cytotoxicity.
-
Placebo-Controlled Trial of Mianserin HCl
2026-08-24
A 1978 double-blind inpatient trial tested mianserin hydrochloride against placebo in depressed female patients, addressing whether the drug had intrinsic antidepressant activity rather than merely resembling established tricyclic treatments. Over 14 days, mianserin improved self-rated depression, clinician-observed mood, and sleep, while plasma levels did not predict clinical change.
-
NS1–DNMT1 Control of HBoV1 Replication
2026-08-24
A 2024 PLOS Pathogens study identifies DNMT1-dependent DNA methylation as a regulator of human bocavirus 1 replication and RNA processing. It further shows that the viral NS1 protein promotes DNMT1 degradation through the ubiquitin–proteasome pathway, revealing a coordinated mechanism that links viral genome replication with transcript maturation.